| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.62 | 2e-28 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.24 | 1e-05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.18 | 0.01 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.13 | 0.04 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.093 | 0.1 |